Seventeen analogs of the luteinizing hormone releasing hormone (LHRH) have been synthesized, bioassayed, and compared for antiovulatory activity (AOA) in rats. The emphasis of design was replacement of Tyr 5 of LHRH. Position 5 has not been extensively studied. 
Introduction
Investigators since about 1971, have synthesized and bioassayed about 1800 analogs of the luteinizing hormone releasing hormone (LHRH) toward achieving super-agonists and effective antagonists for the control of conception. This very large number of analogs stemmed largely from international and academic investigators; the very large number of analogs which have been industrially achieved is unknown. The present goals for antagonists, having antiovulatory activity, are even higher potency, effective duration of action, and no toxicity. From this enormous literature, the following investigations are cited to exemplify recent progress, and to provide background for the new analogs herein.
Folkers et al. [1] found that antagonists of LHRH with pyridyl-alanines completly inhibited ovulation in rats at ng dosage. D-3-Pal was frequently superior to D-Trp. Analogs having a moiety of ß-(3-quinolyl)-D-a-alanine in positions 3 and 6 were synthesized. D-3-Qal 6 was as effective as D-Trp 6 in certain analogs; Folkers et al. [2] .
Rivier et al. [3] reported on the effects of gonadotropin releasing agonists and antagonists on reproductive function. Coy et al. [4] administered agonistic and antagonistic analogs of LHRH to Macaca fascicularia to evaluate LHRH-induced anovulations. Meso et al. [5] studied the role of N-acetyl groups on amino acid was attached to the resin, and the coupling programs were essentially as described [8, 9] . The resin, after the first amino acid was attached, was acetylated by 25% acetic anhydride in dichloromethane in the presence of pyridine in a reaction time of 20 min. The peptides were removed from the resin by treatment with doubly distilled (CoF 3 ) HF containing ca. 10% anisole for 1 h at 0 °C.
Purification and purity
After HF-cleavage, the peptides were lyophilized; the yield was about 300-400 mg from 0. 
Amino acid analyses
The amino acid analyses, after conventional acid hydrolyses, were performed on a Beckman 118 CL Automatic Amino Acid Analyzer with a Hewlett Packard 3390 A intergrator. Tryptophan and unnatural amino acids were qualitatively determined. The chemical data, and the amino acid data on the peptides are in Tables II and III .
Biological assays
The peptides were bioassayed for activity to inhibit ovulation in rats [10] . The data from the bioassays are in Table I . 
Results and Discussion
The data in Table I are on 17 analogs of LHRH which were synthesized and bioassayed for antiovulatory activity (AOA) in rats. The primary emphasis in the design of these analogs was to make substitutions for the intrinsic Tyr 5 of LHRH. As the base line, analog 1 was selected which has the intrinsic Tyr 5 of LHRH, and is one of the most potent known antagonists; it caused 100% AO A at 0.5 jug and 57% AOA at 0.25 pig. It is known in this field of research that antagonists which show 100% AOA in the range of 0.25-0.5 jug are recently among the best. In this field, substitutions in position 5 of highly potent antagonists have been less explored than those for positions 1, 2, 3, 6, 10, etc.
The L configuration was maintained for the substitutions in position 5 of the 17 analogs. McDermott et al. [11] investigated the mechanism of degradation of LHRH by synaptosomal peptidases. The synaptosomes were isolated from rat hypothalamus cortex. It was found that LHRH was cleaved at Tyr 5 -Gly 6 and Pro 9 -Gly 10 .
The introduction of a-MeTyr 5 toward surpressing enzymic cleavage between positions 5 and 6 decreased activity to about one-half in comparison with the base line antagonist. Roeske et al. [12] 
